Table 1.
Descriptive characteristics of the study participants.
| N | Mean | SD | |
|---|---|---|---|
| Age (years) | 77 | 43.2 | 13.8 |
| Weight (kg) | 77 | 65.1 | 11.1 |
| Height (cm) | 77 | 160.1 | 6.8 |
| BMI (kg/m2) | 77 | 25.5 | 4.5 |
| FMI (kg/m2) | 77 | 9.23 | 3.87 |
| Waist circumference (cm) | 77 | 81.7 | 10.7 |
| Hip circumference (cm) | 77 | 98.1 | 9.9 |
| Waist-to-height ratio (units) | 77 | 0.51 | 0.07 |
| Waist-to-hip ratio (units) | 77 | 0.83 | 0.06 |
| Back-Scratch test (cm) | 76 | −0.8 | 9.6 |
| Handgrip strength (kg) | 76 | 23.6 | 5.3 |
| Chair stand test (rep) | 77 | 14.9 | 3.1 |
| 6MWT (m) | 49 | 570.8 | 71.7 |
| VO2max estimated (mL/kg/min) | 49 | 24.4 | 3.2 |
| SLEDAI (score) | 77 | 0.68 | 1.5 |
| SDI (score) | 77 | 0.55 | 1.11 |
| Duration of SLE (years) | 77 | 13.9 | 10.1 |
| Accumulated corticosteroid dose (last 3 years; mg) | 77 | 2875 | 2677 |
| Dyslipidemia (%) | 77 | 18 | |
| Diabetes (%) | 77 | 1 | |
| Arterial hypertension (%) | 77 | 17 | |
| Smokers (%) | 77 | 53 | |
| Statins intake (%) | 77 | 18 | |
| Antidiabetic drugs intake (%) | 77 | 3 | |
| Corticosteroid dose (%; mg/d) | 77 | 65 |
FMI: Fat mass index; BMI: Body mass index; SLEDAI: Systemic lupus erythematosus disease activity index; SDI: Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index; 6MWT: 6 min walk test; SLE: Systemic lupus erythematosus. All variables show mean and SD values except accumulated corticosteroid dose, dyslipidemia, diabetes, arterial hypertension, smokers, statins intake, antidiabetic drugs intake, and corticosteroid dose.